{
    "2021-07-16": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：公立医院高质量发展试点先行 加快优质医疗资源扩容布局",
                "features": {
                    "keywords": [
                        "公立医院",
                        "高质量发展",
                        "优质医疗资源",
                        "扩容布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药与国际医学达成战略合作，打造一流研究型医院和高质量研究服务平台",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "战略合作",
                        "研究型医院",
                        "研究服务平台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "数字化创新赋能临床研究，泰格医药基于风险的质量管理（RBQM）系统精彩上线",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "数字化创新",
                        "临床研究",
                        "RBQM系统"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[权益变动] 泰格医药(03347.HK)被瑞银减持19.38万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "瑞银",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "受益于政策红利，泰格医药市占率有望进一步提升。",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "政策红利",
                        "市占率",
                        "提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股高位回调：北上资金大举减仓锂电龙头，反手抄底大白马",
                "features": {
                    "keywords": [
                        "A股",
                        "高位回调",
                        "北上资金",
                        "锂电龙头",
                        "大白马"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "Canada Pension Plan Investment Board增持泰格医药(03347)13.18万股，每股作价约176.14港元",
                "features": {
                    "keywords": [
                        "Canada Pension Plan Investment Board",
                        "泰格医药",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[权益变动] 泰格医药(03347.HK)获Canada Pension Plan Investment Board两日增持56.1544万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "Canada Pension Plan Investment Board",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "外资减仓融资客加码，新能源板块现资金分歧",
                "features": {
                    "keywords": [
                        "外资",
                        "减仓",
                        "融资客",
                        "加码",
                        "新能源",
                        "资金分歧"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}